Insmed Incorporated INSM is trading higher on the session after disclosing share buying by an insider. According to an SEC filing, the company's director Melvin Sharoky bought approximately 20,000 shares at $3.00 per share.
Additionally, Insmed disclosed yesterday after the close that it filed for a $75 million mixed securities shelf. This disclosure made the shares tick lower in after hours trading.
Insmed is currently trading at $3.38, a gain of $0.36 or 11.92% intraday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Intraday UpdateMovers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in